Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.
about
Update on primary ovarian insufficiencyPrescribing of FDA-approved and compounded hormone therapy differs by specialty.The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.A Scalable and Versatile Synthesis of Oxime-Based Hormone Dimers and Gels for Sustained Release.
P2860
Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@ast
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@en
type
label
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@ast
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@en
prefLabel
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@ast
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@en
P2093
P2860
P1476
Bioidentical hormones, menopau ...... " in U.S. anti-aging medicine.
@en
P2093
Jennifer R Fishman
Michael A Flatt
Richard A Settersten
P2860
P356
10.1016/J.SOCSCIMED.2015.02.027
P407
P577
2015-02-19T00:00:00Z